圣裘德的AI驱动平台Combocat加速发现有效治疗癌症和其他疾病的药物组合。 St. Jude's AI-driven platform Combocat accelerates discovery of effective drug combos for cancer and other diseases.

由圣裘德儿童研究医院开发的新机器学习动力平台Combocat正在加速发现癌症等疾病的有效药物组合。 A new machine learning-powered platform called Combocat, developed by St. Jude Children’s Research Hospital, is speeding up the discovery of effective drug combinations for diseases like cancer. 利用先进的液体处理和人工智能,它有效地测试了数千对药物,确定协同处理速度更快,废物较少。 Using advanced liquid-handling and AI, it efficiently tests thousands of drug pairs, identifying synergistic treatments faster and with less waste. 该工具以两种方式运作,即详细和零散平衡的准确性和速度。 The tool operates in two modes—detailed and sparse—balancing accuracy and speed. 在对神经细胞进行测试后,它成功地发现了有希望的组合,实验结果也证实了这一点。 Tested on neuroblastoma cells, it successfully found promising combinations, with results confirmed experimentally. Combocat现在开放源头,可以免费获得,其目的是推动精密药品和药物在多种疾病中的开发。 Now open-source and freely available, Combocat aims to advance precision medicine and drug development across multiple diseases.